Avandia and Heart Attacks

connection between avandia and heart attacks prompts safety alert

avandia diabetes insulinAs many as 100,000 heart attacks may be linked to , according to Sen. Charles Grassley (R-Iowa) in a floor statement placed in the Senate record on May 24, 2007.

, sold by the British company PLC, is a blockbuster medication used to treat Type 2 , the most common form of the disease. More than 6 million people worldwide have taken the drug, whose U.S. sales topped $2.2 billion last year.

Analysis led by Cleveland Clinic cardiology chief Dr. Steven Nissen of 42 separate studies on concluded that it raised the risk of heart attacks by 43 percent, compared to the rates among people taking no or other drugs. The analysis also indicated that might increase the risk of heart-related deaths.

Any increase in risk is especially worrisome for diabetics because two-thirds of them die of heart problems.

About 1 million Americans are currently taking , which costs from $90 to $170 for a one-month supply.

The and experts are advising users of to talk to their doctors and not to immediately discontinue the drug.

Learn more about Avandia side effects.

free legal consultation

If you or a loved one have suffered serious side effects while taking , if you have been diagnosed with blood clots, , or stroke, or if you are experiencing the symptoms associated with any of these serious side effects, you may have a claim against the manufacturer of .

Please contact us today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.

Latest News

FDA announces it will review studies linking Avandia to heart attacks

fda logo 100x100It’s a long time coming. This week the Food and Drug Administration () announced it is reviewing the primary data from a large, long-term clinical study, known as RECORD, on possible cardiovascular risks associated with the drug Avandia (rosiglitazone). The agency said it is also reviewing on an ongoing basis a number of other published observational studies on the cardiovascular safety of the drug. The ’s announcement comes on the heels of news that two U.S. senators are asking why the (GSK) drug is still on the market when an oversight board in 2008 urged the agency to pull the drug because it was causing 500 additional heart attacks a month. That request by the oversight board was based on the findings from the RECORD study.

Read the rest of this entry »

Senators ask why dangerous Avandia was not pulled from market

avandiabottle 100x100Two U.S. senators are asking the Food and Drug Administration () why the drug Avandia is still on the market after an agency oversight board in 2008 urged the agency to remove the (GSK) drug from the market because it was causing 500 additional heart attacks a month. Senators Max Baucus and Charles Crassley said the major drug company even knew about the dangers of but initiated a cover up to keep the drug available to consumers.

Read the rest of this entry »

Doctors and critics doubt the accuracy of Avandia study

avandiabottle 100x100Results of a clinical study announced in New Orleans recently appeared to exonerate Avandia from long-held suspicions that the drug causes adverse cardiovascular events in patients undergoing treatment for 2. Many doctors and other critics, however, say that the study is flawed and remain unconvinced of the findings. Financial analysts believe the results will likely give ’s one-time blockbuster drug a sales boost.

Read the rest of this entry »